A US-based study on mice and human brain tissue samples has claimed the mosquito-borne Zika virus can destroy cells responsible for glioblastoma, the most common form of brain cancer. The secret to Zika's apparent success, researchers said, is that the virus targets cancerous stem cells, which generally survive standard chemotherapy. The team hopes to begin human trials within 18 months.